Esperion Therapeutics: Still An Attractive Risk/Reward Narrative As The Earnings Clock Ticks Toward Profitability

Esperion Therapeutics stock remains a buy as strong drug franchises, growth, and global milestones outweigh risks. Learn more ...

Buy, Sell or Hold Baidu Stock? Key Tips Ahead of Q3 Earnings

BIDU heads into Q3 with rising AI and autonomous momentum but faces softer advertising trends and heavier investment pressure.

Celsia SA Esp (BOG:CELSIA) Q3 2025 Earnings Call Highlights: Record Revenue Surge and Strategic ...

Celsia SA Esp (BOG:CELSIA) reports a remarkable 173% revenue growth, strategic partnerships, and global expansion, despite facing integration challenges.
Zacks.com on MSN

CELH to Report Q3 Earnings: Buy, Sell or Hold the Stock Now?

CELH's Q3 momentum builds on brand strength, Alani Nu integration and expanding reach amid rising wellness trends.
exchange4media

e4m Media Ace Awards 2025: WPP Media, YAAP, EssenceMediacom among top winners

WPP India's CVL Srinivas conferred with Lifetime Achievement Award; Prasanth Kumar, Navin Khemka, Atul Hegde, among other key ...
sharewise

4 Likely Retail Winners Investors Shouldn't Miss This Earnings Season

As investors await upcoming earnings reports, the performance of key players within the Retail-Wholesale sector could impact ...

Should You Buy, Sell, or Hold BROS Stock Before Q3 Earnings Release?

Dutch Bros heads into Q3 earnings with strong traffic, menu innovation and digital loyalty momentum. Yet higher costs may ...
Zacks.com on MSN

DraftKings Gears Up for Q3 Earnings: What's in the Offing?

DraftKings Inc. DKNG is scheduled to report third-quarter 2025 results on Nov. 6, after the closing bell. In the last ...

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q3 2025 Earnings Call Transcript

Q3 2025 Earnings Call Transcript November 6, 2025 Esperion Therapeutics, Inc. misses on earnings expectations. Reported EPS ...